Trevi Therapeutics, Inc. (TRVI)
NASDAQ·Healthcare·Biotechnology
$13.80
-3.29%
Mkt Cap $1.82B
Analyst Ratings
Buy
15
Hold
0
Sell
0
Price Target (7 analysts)
$19.25
Range $16.00 – $24.00
Implied Upside
+39.5%
Consensus $19.25 vs current $13.80
NASDAQ·Healthcare·Biotechnology
$13.80
-3.29%
Mkt Cap $1.82B
Buy
15
Hold
0
Sell
0
Price Target (7 analysts)
$19.25
Range $16.00 – $24.00
+39.5%
Consensus $19.25 vs current $13.80